Zobrazeno 1 - 10
of 4 122
pro vyhledávání: '"ANTIHYPERTENSIVE TREATMENT"'
Publikováno v:
Xin yixue, Vol 55, Iss 4, Pp 248-254 (2024)
Hypertension is a serious public health problem worldwide and a major risk factor for cardiovascular disease. Hypertensive patients are constantly complicated with cardiovascular disease. Effective blood pressure control could improve clinical progno
Externí odkaz:
https://doaj.org/article/dd447c3cd4d54e6a90344e953a61fd60
Autor:
Jian-Feng Huang, Dong-Yan Zhang, De-Wei An, Ming-Xuan Li, Chang-Yuan Liu, Ying-Qing Feng, Qi-Dong Zheng, Xin Chen, Jan A. Staessen, Ji-Guang Wang, Yan Li, Yi-Qing Zhang, Gui-Li Chang, Zhe Hu, Xi-Da Li, Can Liu, Jia-Yi Huang, Yu-Ling Yu, Yi-Yun Wang, Xue-Ning Zhang, Jing Yu, Rui-Xin Ma, Heng-Xia Liu, Xiao-Ping Chen, Qing-Tao Meng, Zhi-Peng Zhang, Yu Dou, Mei-Yu Zhu, Wen-Juan Wang, Li-Li Zhu, Min Zhang, Yi-Nong Jiang, Yan Lu, Wei Yu, Xiao-Ling Xu, Qiu-Yan Dai, Yu-Feng Zhu, Hui-Jie Zhang, Yu Zhang, Jin-Shun Zhang, Pei-Li Bu, Ling-Xin Liu, Jian-Jun Mu, Jing-Tao Xu, Yue-Yuan Liao, Hao Guo, Xin-Yue Liang
Publikováno v:
EClinicalMedicine, Vol 74, Iss , Pp 102736- (2024)
Summary: Background: Masked hypertension is associated with target organ damage (TOD) and adverse health outcomes, but whether antihypertensive treatment improves TOD in patients with masked hypertension is unproven. Methods: In this multicentre, ran
Externí odkaz:
https://doaj.org/article/a1c82d3a3f1a4437912d902702104456
Publikováno v:
Patient Preference and Adherence, Vol Volume 17, Pp 3331-3339 (2023)
Salpe Malkon,1 Björn Wettermark,1 Thomas Kahan,2 Pia Bastholm-Rahmner,3 Jan Hasselström,4 Miriam Qvarnström1 1Department of Pharmacy, Uppsala University, Uppsala, Sweden; 2Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital,
Externí odkaz:
https://doaj.org/article/d67a4d5ecd21468b88ce7b9b10af665b
Autor:
Yuma Shibutani, Kazuko Tajiri, Shinya Suzuki, Tomohiro Enokida, Atsunobu Sagara, Susumu Okano, Takao Fujisawa, Fumiaki Sato, Tetsuro Yumoto, Motohiko Sano, Toshikatsu Kawasaki, Makoto Tahara
Publikováno v:
Cancer Medicine, Vol 12, Iss 22, Pp 20773-20782 (2023)
Abstract Background Hypertension is the most frequently occurring adverse event of lenvatinib, recognized relatively early in its course. However, the trend in blood pressure after the initiation of lenvatinib and the outcomes with antihypertensive t
Externí odkaz:
https://doaj.org/article/25332373f7da40b29df12ef342640d17
Publikováno v:
BMC Cardiovascular Disorders, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Objective To determine the association between different antihypertensive regimens and cardiovascular disease (CVD) outcomes in hypertensive patients. Method This single center retrospective cohort study analyzed 602 hypertensive patients wi
Externí odkaz:
https://doaj.org/article/78970c59fd914b0fb7cec3fb2d512090
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 2 (2024)
Aim. To study changes in blood pressure (BP) in patients with acute hemispheric ischemic stroke (AIS), to correlate BP in patients with AIS with BP in patients with chronic brain ischemia, and to study the association of various BP indices with strok
Externí odkaz:
https://doaj.org/article/4343165db220489a9ec78f0ee231bcae
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 35, Iss 1, Pp 1-6 (2023)
Abstract Background Malignant hypertension is a model of the rapid changes that a high afterload and renin-angiotensin levels can induce on target organs such as the heart. We present a case of a young man affected by malignant hypertension with mult
Externí odkaz:
https://doaj.org/article/d4890e3a8dba44c7917fe2990add9ab6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
T. O. Brodovskaya, D. V. Kasyanov
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 12 (2023)
The diagnosis of hypertension (HTN) has been known to doctors for many years. Current clinical guidelines represent a unified approach to the treatment and prevention of hypertension in patients of both sexes. Meanwhile, there are data that the devel
Externí odkaz:
https://doaj.org/article/5e2aaab3dd9f46798a3e93528d63001b
Autor:
Giuseppe Mancia, Guido Grassi, Enrico Agabiti-Rosei, Claudio Borghi, Maria Lorenza Muiesan, Paolo Palatini, Gianfranco Parati, Stefano Taddei, Reinhold Kreutz
Publikováno v:
Italian Journal of Medicine, Vol 17, Iss 3 (2023)
The 2023 hypertension guidelines of the European Society of Hypertension (ESH) have been published in the December issue of the official Journal of the Society (Journal of Hypertension),1 where they are freely available online. Compared to the guidel
Externí odkaz:
https://doaj.org/article/d89201b11ca24687a4081a2d3449df5a